Latest news with #SmartFactory
Business Wire
7 days ago
- Business
- Business Wire
Cellares and Mitsui Fudosan Announce the First IDMO Smart Factory for Commercial-Scale Cell Therapy Manufacturing in Japan
SOUTH SAN FRANCISCO, Calif. & TOKYO--(BUSINESS WIRE)-- Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui Fudosan, announces the establishment of Japan's first next-gen commercial production site for CAR-T cell therapies. The facility is under construction in Kashiwa City, a vibrant urban center located approximately 30 kilometers northeast of central Tokyo in Chiba Prefecture. As part of the extensive Tokyo metropolitan region, Kashiwa serves as a booming biotech hub. This groundbreaking Integrated Development and Manufacturing Organization (IDMO) Smart Factory is expected to provide employment to 350 people while enabling scalable and cost-effective cell therapy manufacturing, addressing an urgent need for patients in Japan and neighboring regions. The facility, set to open in partnership with Mitsui Fudosan, will utilize Cellares' state-of-the-art technology platforms, the Cell Shuttle™ and Cell Q™, to automate cell therapy manufacturing and quality control. The technology reduces batch prices by up to 50% and eliminates the manufacturing bottlenecks faced by conventional CDMOs that use manual processes. Additionally, the entire Smart Factory will be integrated and optimized to eliminate any downstream bottlenecks as well. 'Cellares' new facility in Kashiwa City will enable our pharma clients to supply Japan from Japan. Manufacturing cell therapies locally simplifies cold chain logistics, accelerates vein-to-vein time and reduces cost,' said Fabian Gerlinghaus, CEO and Co-Founder of Cellares. 'Our Japanese IDMO Smart Factory is part of a broader strategy to be a global manufacturing partner for our clients and meet the total patient demand for cell therapies around the world.' The new site's impact extends beyond patient care. By accelerating the availability of CAR-T treatments, this initiative has the potential to help advance the development and approval of CAR-T therapeutics in Japan. Once the IDMO Smart Factory is online, technical transfers between Cellares facilities in other regions are expected to be a seamless, rapid, software-enabled process. Thanks to fully automated processes on standardized technologies, tech transfer can now happen at digital speed. Dr. Toshihiko Doi, the Chairperson of the Kashiwa-no-ha Life Science Committee, shared, 'For cancer patients in Japan, the establishment of this facility provides access to cutting-edge therapies that can make a critical difference in their fight against diseases. It marks a significant step toward eliminating the drug delivery lag time that has been a challenge for rare disease and oncology treatments.' Mitsui Fudosan's robust network in Japan's life sciences industry has been instrumental in enabling this collaboration, ensuring the smooth dissemination of information to the pharmaceutical industry, government agencies, and the broader healthcare community. This announcement represents Cellares' commitment to expanding its footprint in Japan, paving the way for further collaborations and innovations. For more information, visit About Cellares Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company's Cell Shuttle™ integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers end-to-end automation. While the Cell Shuttle automates cell therapy manufacturing, the Cell Q™ automates quality control at high throughput, both for in-process and release QC. Cell Shuttles™ and Cell Qs™ will be deployed in Cellares' Smart Factories around the world, enabling each Smart Factory to produce 10 times as many cell therapy batches as a conventional CDMO with the same facility size and headcount. Partnering with Cellares enables academic medical centers, biotechnology companies, and pharmaceutical companies to accelerate cell therapy development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand. The company is headquartered in South San Francisco, California with its first commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. Cellares is building a global network of IDMO Smart Factories, with additional facilities under construction in Europe and Japan. The company is backed by world-class investors and has raised over $355 million in financing. For more information about Cellares, please visit About Mitsui Fudosan Co. Mitsui Fudosan is working to create new industries during this time of change in society and the economy. As a "Platformer," the company provides "Places" and "Communities" that bring together the ideas of companies, society, and individuals. In April 2024, it launched a Group's New Long-Term Vision, setting a strategy to explore areas beyond real estate. To support this, Innovation Promoting Division was established to drive innovation and help create new industries. At Kashiwa-no-ha Smart City, Mitsui Fudosan works with the public, private, and academic sectors to create a community where people can live healthy lives and where new life science industries can grow.
Associated Press
17-03-2025
- Business
- Associated Press
Nulogy's Kevin Wong Recognized in 2025 Pros to Know by Supply & Demand Chain Executive
Nulogy co-founder and COO leads the way in solving complex supply chain challenges TORONTO, March 17, 2025 /PRNewswire/ - Nulogy, a leader in collaborative manufacturing and supply chain solutions, is pleased to announce that Kevin Wong, Chief Operating Officer, has been recognized by Supply & Demand Chain Executive as a recipient of this year's Pros to Know award. This award recognizes outstanding executives whose accomplishments offer a roadmap for other leaders looking to leverage supply chains for competitive advantage. This recognition is for the Leaders in Excellence category. As COO and co-founder of Nulogy, Kevin has been a driving force behind the company's product vision and strategy, shaping purpose-built solutions that address the unique challenges of complex multi-enterprise supply chains. With deep expertise in both technology and supply chain collaboration, Kevin has been instrumental in helping Nulogy's customers—including brand manufacturers such as Colgate-Palmolive, L'Oréal and Church & Dwight—gain the visibility and agility needed to thrive in today's dynamic markets. Kevin's influence extends beyond Nulogy, as an active contributor to the broader supply chain community through his involvement in trusted industry organizations such as the Foundation for Supply Chain Solutions, the Visibility Council and Association for Supply Chain Management. With a recent focus on integrating new manufacturing productivity capabilities into Nulogy's platform through its Smart Factory solution, Kevin is committed to evolving a product offering that not only delivers real-time data visibility, but also creates shared value for all partners in an external manufacturing network. 'I'm deeply passionate about helping brand owners and their external partners work better together. Supply chains are incredibly dynamic, and strong partnerships–supported by the right, purpose-built technology–are essential for remaining competitive,' said Kevin. 'I'm excited to keep working alongside our customers to deliver solutions that make collaboration easier, faster and more valuable for everyone involved.' 'Many of today's supply chain pros are more than just leaders within their space; they're true pioneers of change. This year's list of winners really pushed the boundaries in all facets; creating, implementing, transforming, innovating, reinventing, and collaborating. They executed on all fronts, over-delivering and over-performing. They are true professionals to know in the supply chain space,' says Marina Mayer, editor-in-chief of Food Logistics and Supply & Demand Chain Executive and co-founder of the Women in Supply Chain Forum. Click here to view the full list of winners. About Nulogy Nulogy, a leading supplier of cloud-based supply chain solutions, enables customers and their supplier communities to collaborate on a multi-enterprise platform to deliver with excellence to an ever-changing consumer market. The Nulogy platform orchestrates upstream supply ecosystems composed of brands, contract manufacturers and packagers, third party logistics providers, and raw material and packaging suppliers to accelerate supply chain responsiveness and agility at the speed of today's market. About Supply & Demand Chain Executive Supply & Demand Chain Executive is the only supply chain publication covering the entire global supply chain, focusing on trucking, warehousing, packaging, procurement, risk management, professional development and more. Supply & Demand Chain Executive and its sister publication, Food Logistics, also operate SCN Summit and the Women in Supply Chain Forum. Go to to learn more.
